WallStSmart
WVE

Wave Life Sciences Ltd

NASDAQ: WVE · HEALTHCARE · BIOTECHNOLOGY

$7.06
+0.14% today

Updated 2026-04-30

Market cap
$1.36B
P/E ratio
P/S ratio
18.89x
EPS (TTM)
$-1.05
Dividend yield
52W range
$5 – $22
Volume
4.6M

Wave Life Sciences Ltd (WVE) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-16.2%
Last 4 quarters
Revenue YoY growth
-79.4%
Most recent quarter
EPS YoY growth
-276.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.4%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-7.6%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$-0.30-10.9%$13.29$14.08+5.9%
2025-11-10$-0.32-25.6%$7.86$7.26-7.6%
2025-07-30$-0.31-14.8%$8.32$8.10-2.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.27$-0.30-10.9%$17.25M-79.4%
2025-09-30$-0.25$-0.32-25.6%$7.61M-199.1%
2025-06-30$-0.27$-0.31-14.8%$8.70M-55.8%
2025-03-31$-0.26$-0.29-13.5%$9.18M-26.8%
2024-12-31$-0.17$0.17+200.0%$83.75M+188.2%
2024-09-30$-0.28$-0.47-66.4%$-7.68M-115.6%
2024-06-30$-0.21$-0.25-19.0%$19.69M-10.9%
2024-03-31$-0.21$-0.24-14.3%$12.54M
2023-12-31$-0.23$-0.15+34.8%$29.06M
2023-09-30$-0.18$0.07+138.9%$49.21M
2023-06-30$-0.33$-0.20+39.4%$22.11M

Frequently asked questions

Has Wave Life Sciences Ltd beaten earnings estimates?
Wave Life Sciences Ltd has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -16.2% over the last 4 quarters.
How does WVE stock react to earnings?
WVE stock has moved an average of -1.4% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Wave Life Sciences Ltd's revenue growth rate?
Wave Life Sciences Ltd reported year-over-year revenue growth of -79.4% in its most recent quarter, with EPS growing -276.5% year-over-year.